Interpace Biosciences Stock Technical Analysis
| IDXG Stock | USD 1.85 0.03 1.65% |
As of the 16th of February 2026, Interpace Biosciences retains the Risk Adjusted Performance of 0.127, market risk adjusted performance of (0.55), and Downside Deviation of 7.17. Interpace Biosciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Interpace Biosciences, which can be compared to its competitors. Please check out Interpace Biosciences information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Interpace Biosciences is priced fairly, providing market reflects its last-minute price of 1.85 per share. Please also validate Interpace Biosciences total risk alpha, which is currently at 0.6556 to confirm the company can sustain itself at a future point.
Interpace Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Interpace, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to InterpaceInterpace |
Interpace Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Interpace Biosciences' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Interpace Biosciences.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Interpace Biosciences on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Interpace Biosciences or generate 0.0% return on investment in Interpace Biosciences over 90 days. Interpace Biosciences is related to or competes with LFTD Partners. Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating c... More
Interpace Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Interpace Biosciences' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Interpace Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.17 | |||
| Information Ratio | 0.1386 | |||
| Maximum Drawdown | 54.19 | |||
| Value At Risk | (10.71) | |||
| Potential Upside | 15.79 |
Interpace Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Interpace Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Interpace Biosciences' standard deviation. In reality, there are many statistical measures that can use Interpace Biosciences historical prices to predict the future Interpace Biosciences' volatility.| Risk Adjusted Performance | 0.127 | |||
| Jensen Alpha | 1.49 | |||
| Total Risk Alpha | 0.6556 | |||
| Sortino Ratio | 0.179 | |||
| Treynor Ratio | (0.56) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Interpace Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Interpace Biosciences February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.127 | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 6.32 | |||
| Semi Deviation | 5.6 | |||
| Downside Deviation | 7.17 | |||
| Coefficient Of Variation | 684.33 | |||
| Standard Deviation | 9.26 | |||
| Variance | 85.82 | |||
| Information Ratio | 0.1386 | |||
| Jensen Alpha | 1.49 | |||
| Total Risk Alpha | 0.6556 | |||
| Sortino Ratio | 0.179 | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 54.19 | |||
| Value At Risk | (10.71) | |||
| Potential Upside | 15.79 | |||
| Downside Variance | 51.43 | |||
| Semi Variance | 31.37 | |||
| Expected Short fall | (8.49) | |||
| Skewness | 1.67 | |||
| Kurtosis | 5.8 |
Interpace Biosciences Backtested Returns
Interpace Biosciences is abnormally volatile given 3 months investment horizon. Interpace Biosciences holds Efficiency (Sharpe) Ratio of 0.17, which attests that the entity had a 0.17 % return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.54% are justified by taking the suggested risk. Use Interpace Biosciences Market Risk Adjusted Performance of (0.55), downside deviation of 7.17, and Risk Adjusted Performance of 0.127 to evaluate company specific risk that cannot be diversified away. Interpace Biosciences holds a performance score of 13 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -2.38, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Interpace Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Interpace Biosciences is expected to outperform it. Use Interpace Biosciences potential upside, as well as the relationship between the kurtosis and day typical price , to analyze future returns on Interpace Biosciences.
Auto-correlation | 0.74 |
Good predictability
Interpace Biosciences has good predictability. Overlapping area represents the amount of predictability between Interpace Biosciences time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Interpace Biosciences price movement. The serial correlation of 0.74 indicates that around 74.0% of current Interpace Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Interpace Biosciences technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Interpace Biosciences Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Interpace Biosciences across different markets.
About Interpace Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Interpace Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Interpace Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Interpace Biosciences price pattern first instead of the macroeconomic environment surrounding Interpace Biosciences. By analyzing Interpace Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Interpace Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Interpace Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
Interpace Biosciences February 16, 2026 Technical Indicators
Most technical analysis of Interpace help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Interpace from various momentum indicators to cycle indicators. When you analyze Interpace charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.127 | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 6.32 | |||
| Semi Deviation | 5.6 | |||
| Downside Deviation | 7.17 | |||
| Coefficient Of Variation | 684.33 | |||
| Standard Deviation | 9.26 | |||
| Variance | 85.82 | |||
| Information Ratio | 0.1386 | |||
| Jensen Alpha | 1.49 | |||
| Total Risk Alpha | 0.6556 | |||
| Sortino Ratio | 0.179 | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 54.19 | |||
| Value At Risk | (10.71) | |||
| Potential Upside | 15.79 | |||
| Downside Variance | 51.43 | |||
| Semi Variance | 31.37 | |||
| Expected Short fall | (8.49) | |||
| Skewness | 1.67 | |||
| Kurtosis | 5.8 |
Interpace Biosciences February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Interpace stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.02 | ||
| Daily Balance Of Power | 1.00 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 1.84 | ||
| Day Typical Price | 1.84 | ||
| Price Action Indicator | 0.03 | ||
| Market Facilitation Index | 0.03 |
Complementary Tools for Interpace OTC Stock analysis
When running Interpace Biosciences' price analysis, check to measure Interpace Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Interpace Biosciences is operating at the current time. Most of Interpace Biosciences' value examination focuses on studying past and present price action to predict the probability of Interpace Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Interpace Biosciences' price. Additionally, you may evaluate how the addition of Interpace Biosciences to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |